Bristol Consumer Unit Suitors Tasked With Determining Value Of Excedrin
This article was originally published in The Tan Sheet
Executive Summary
Bristol-Myers Squibb says it will contact potential buyers for its North American Consumer Medicines division "over the coming weeks.
You may also be interested in...
Novartis Purchase Of Bristol OTCs Has Excedrin Written All Over It
Novartis will enter the U.S. over-the-counter analgesics market with Excedrin as part of the purchase of Bristol-Myers Squibb's OTC portfolio
OTC M&A Trend May Be Result Of Too Many Large Players At The Top – Panel
A lack of competitive global scale may be one factor fueling the divestiture of OTC units by larger pharma companies
Bristol Consumer Package Will Include OTC Pravachol
Royalties from OTC Pravachol would be included in a sale of Bristol-Myers Squibb's consumer brands